Literature DB >> 16039334

Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis.

M B Delatycki1, K J Allen, A E Nisselle, V Collins, S Metcalfe, D du Sart, J Halliday, M A Aitken, I Macciocca, V Hill, A Wakefield, A Ritchie, A A Gason, A J Nicoll, L W Powell, R Williamson.   

Abstract

HFE-associated hereditary haemochromatosis is a recessive, iron-overload disorder that affects about one in 200 north Europeans and that can be easily prevented. However, genetic screening for this disease is controversial, and so we assessed whether such screening was suitable for communities. Cheek-brush screening for the Cys282Tyr HFE mutation was offered to individuals in the workplace. Outcomes were assessed by questionnaires before and after testing. 11,307 individuals were screened. We recorded no increase in anxiety in individuals who were homozygous for the Cys282Tyr mutation or non-homozygous. Self-reported tiredness before testing was significantly higher in homozygous participants than in non-homozygous participants (chi2 test, p=0.029). Of the 47 homozygous individuals identified, 46 have taken steps to treat or prevent iron accumulation. Population genetic screening for HFE-associated hereditary haemochromatosis can be practicable and acceptable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039334     DOI: 10.1016/S0140-6736(05)63012-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

Review 1.  Phenotypic expression of hereditary hemochromatosis: what have we learned from the population studies?

Authors:  Eng K Gan; Oyekoya T Ayonrinde; Debbie Trinder; John K Olynyk
Journal:  Curr Gastroenterol Rep       Date:  2010-02

2.  The diagnosis and management of hereditary haemochromatosis.

Authors:  Paul Clark; Laurence J Britton; Lawrie W Powell
Journal:  Clin Biochem Rev       Date:  2010-02

Review 3.  A diagnostic approach to hemochromatosis.

Authors:  Anthony S Tavill; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2006-08       Impact factor: 3.522

4.  In response to Cadet et al.

Authors:  M B Delatycki; K J Allen
Journal:  J Med Genet       Date:  2006-02       Impact factor: 6.318

5.  The importance of program evaluation: how can it be applied to diverse genetics education settings?

Authors:  Sylvia A Metcalfe; MaryAnne Aitken; Clara L Gaff
Journal:  J Genet Couns       Date:  2008-02-05       Impact factor: 2.537

6.  Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.

Authors:  Sophie G Zaloumis; Katrina J Allen; Nadine A Bertalli; Lidija Turkovic; Martin B Delatycki; Amanda J Nicoll; Christine E McLaren; Dallas R English; John L Hopper; Graham G Giles; Gregory J Anderson; John K Olynyk; Lawrie W Powell; Lyle C Gurrin
Journal:  J Gastroenterol Hepatol       Date:  2015-04       Impact factor: 4.029

7.  HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.

Authors:  Katrina J Allen; Nadine A Bertalli; Nicholas J Osborne; Clare C Constantine; Martin B Delatycki; Amy E Nisselle; Amanda J Nicoll; Dorota M Gertig; Christine E McLaren; Graham G Giles; John L Hopper; Gregory J Anderson; John K Olynyk; Lawrie W Powell; Lyle C Gurrin
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

8.  Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Gordon D McLaren; Victor R Gordeuk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

9.  Biological variability of transferrin saturation and unsaturated iron-binding capacity.

Authors:  Paul C Adams; David M Reboussin; Richard D Press; James C Barton; Ronald T Acton; Godfrey C Moses; Catherine Leiendecker-Foster; Gordon D McLaren; Fitzroy W Dawkins; Victor R Gordeuk; Laura Lovato; John H Eckfeldt
Journal:  Am J Med       Date:  2007-11       Impact factor: 4.965

10.  Screening for hemochromatosis by measuring ferritin levels: a more effective approach.

Authors:  Jill Waalen; Vincent J Felitti; Terri Gelbart; Ernest Beutler
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.